RNL (rhenium-186-chelated nanoliposome) - Plus Therap
Plus Therapeutics Announces Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting (GlobeNewswire) - Apr 8, 2022 - "Plus Therapeutics...announced that the company will present a poster at the upcoming American Association for Cancer Research (AACR) 2022 Annual Meeting, which is being held April 8-13, 2022, in New Orleans, La., and virtually." 
Clinical • Brain Cancer • CNS Tumor • Glioblastoma • Glioma • Oncology • Solid Tumor
https://www.globenewswire.com/news-release/2022/04/08/2419522/0/en/Plus-Therapeutics-Announces-Poster-Presentation-at-the-American-Association-for-Cancer-Research-AACR-Annual-Meeting.html
 
Apr 8, 2022
 
Prev Next